VV
Versa Vascular
United States · Healthtech · Hardware · Enterprise software
Develops a transcatheter device for minimally invasive tricuspid valve repair
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $42M | BioStar Capital — Role not disclosedS3 Ventures — Role not disclosedSanta Cruz Ventures — Role not disclosed |